Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steven Frankel maintains a Buy rating on Dolby Laboratories (NYSE:DLB) with a $98 price target.
June 07, 2024 | 12:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Steven Frankel maintains a Buy rating on Dolby Laboratories with a $98 price target.
The reaffirmation of a Buy rating and a specific price target of $98 by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100